Moleculin Biotech Inc (MBRX): You're the MAN. Market makers are fo...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	107
Posts	3850
Boards Moderated	0
Alias Born	09/29/2011

keekee

Re: CVTaskForceTeam post# 2598

Monday, 04/13/2020 2:09:37 PM

Monday, April 13, 2020 2:09:37 PM

You're the MAN. Market makers are fools giving away shares under $1. It's free cash gifts!

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MBRX News

Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 12:30:31 PM
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML • PR Newswire (US) • 07/10/2024 12:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 09:00:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 12:00:40 PM
Moleculin Announces Additional Positive Preliminary Interim Data from AML Clinical Trial • PR Newswire (US) • 06/14/2024 12:00:00 PM
Moleculin to Present at the Virtual Investor Pitch Conference • PR Newswire (US) • 06/12/2024 01:00:00 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 06/07/2024 09:05:48 PM
Moleculin to Participate in the Virtual Investor Lunch Break Series • PR Newswire (US) • 06/05/2024 12:55:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 12:32:14 PM
Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress • PR Newswire (US) • 05/16/2024 12:32:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:38:16 PM
Moleculin Announces Commencement of NIH-Funded Phase 2 Clinical Trial of STAT3 Inhibitor for the Treatment of Glioblastoma (NU 21C06) • PR Newswire (US) • 05/15/2024 12:38:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:16:53 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/13/2024 02:53:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 11:30:14 AM
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update • PR Newswire (US) • 05/13/2024 11:30:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:30:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:30:13 PM
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin • PR Newswire (US) • 05/09/2024 12:30:00 PM
Moleculin to Report First Quarter 2024 Financial Results on May 10, 2024 and Host Conference Call and Webcast • PR Newswire (US) • 05/08/2024 12:45:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 12:31:01 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:13:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:55:19 PM
Moleculin Reports Higher AML Complete Remission (CR) Rates and Significant Durability with Additional Interim Subject Data • PR Newswire (US) • 05/07/2024 12:55:00 PM
Moleculin to Host Virtual AML Clinical Day Featuring Internationally Renowned Clinician, Martin S. Tallman, MD, on May 7, 2024 • PR Newswire (US) • 05/02/2024 01:00:00 PM

More MBRX News

InvestorsHub NewsWire

Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM

ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM

Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM

Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover